{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:43:03Z","timestamp":1753922583200},"reference-count":8,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2021,9,1]]},"DOI":"10.1001\/jamaoncol.2021.2084","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T15:32:37Z","timestamp":1626967957000},"page":"1322","source":"Crossref","is-referenced-by-count":1,"title":["High-risk Medulloblastoma\u2014Balancing the High Stakes of Molecular Profiling to Enhance Treatment Responsivity"],"prefix":"10.1001","volume":"7","author":[{"given":"Allison M.","family":"Martin","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadhana","family":"Jackson","sequence":"additional","affiliation":[{"name":"Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland"},{"name":"Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"key":"cic210008r1","article-title":"Efficacy of carboplatin and isotretinoin in children with high-risk medulloblastoma: a randomized clinical trial from the Children\u2019s Oncology Group.","author":"Leary","journal-title":"JAMA Oncol"},{"issue":"9","key":"cic210008r2","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/pbc.v63.9","article-title":"High incidence of veno-occlusive disease with myeloablative chemotherapy following craniospinal irradiation in children with newly diagnosed high-risk CNS embryonal tumors: a report from the Children\u2019s Oncology Group (CCG-99702).","volume":"63","author":"Nazemi","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"21","key":"cic210008r3","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1200\/JCO.2011.40.2792","article-title":"Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children\u2019s Oncology Group Phase I\/II study.","volume":"30","author":"Jakacki","year":"2012","journal-title":"J Clin Oncol"},{"key":"cic210008r4","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.76.4720","article-title":"Extensive molecular and clinical heterogeneity in patients with histologically diagnosed CNS-PNET treated as a single entity: a report from the Children\u2019s Oncology Group Randomized ACNS0332 Trial.","author":"Hwang","year":"2018","journal-title":"J Clin Oncol"},{"issue":"3","key":"cic210008r5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00401-011-0800-8","article-title":"Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH\/WNT molecular subgroups.","volume":"121","author":"Ellison","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"6","key":"cic210008r6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"6","key":"cic210008r7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-016-1569-6","article-title":"Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.","volume":"131","author":"Ramaswamy","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"1","key":"cic210008r8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41568-019-0223-8","article-title":"Medulloblastomics revisited: biological and clinical insights from thousands of patients.","volume":"20","author":"Hovestadt","year":"2020","journal-title":"Nat Rev Cancer"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2782039\/jamaoncology_martin_2021_ic_210008_1631288610.86378.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T15:06:55Z","timestamp":1631804815000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2782039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2021.2084","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,1]]}}}